Tokyo, Japan, Feb 5, 2007 - (JCN Newswire) - Shionogi & Co., Ltd. has launched OxiNorm powder 0.5% (oxycodone hydrochloride hydrate), a powder analgesic for cancer pain, in Japan today. Licensed from Mundipharma, OxiNorm powder 0.5% is an immediate-release powder analgesic for treatment of cancer pain with the same active ingredient as OxyContin(R) Tablets, also under license from Mundipharma, which Shionogi launched in July 2003.
